Diamyd Medical and Cardiff University to collaborate on study monitoring immune response in lymph node cells after administration of Diamyd®

Diamyd Medical today announced a collaboration with Cardiff University on a new study with the diabetes vaccine Diamyd®. The aim of the study is to optimize methods based on ultrasound guided lymph node biopsies for monitoring the cellular immune response to immunotherapy. The study is financed by Cardiff University while Diamyd Medical is supplying the study drug.Diamyd® will be administered intradermally in 12 patients with type 1 diabetes and the immune response will be monitored directly in the lymphatic fluid through ultrasound guided lymph node biopsies. Intradermal administration (